🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10257+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 10257 recruiting trials

Phase 4RecruitingNCT07028125

Digital Monitoring of Self-reported Symptoms by Patients Treated With Cabozantinib Plus Nivolumab for Advanced Clear-cell Renal Carcinoma

🏥 Centre Francois Baclesse📍 10 sites📅 Started Oct 2025View details ↗
Enrolling by InvitationNCT07173790

Watch and Wait or Worry and Wait in Indolent Lymphoma

👨‍⚕️ Ja Min Byun, MD, PhD, Seoul National University Hospital📍 4 sites📅 Started Oct 2025View details ↗
Phase 3RecruitingNCT07203352

Efficacy of Targeted Drugs Combined With Chemotherapy in the Treatment of T-ALL

👨‍⚕️ Qifa Liu, Nanfang Hospital, Southern Medical University📍 1 site📅 Started Oct 2025View details ↗
RecruitingNCT07302321

Needs of ALS Patients With C9orf72 Mutation and Their Caregivers

🏥 Istituto Auxologico Italiano📍 3 sites📅 Started Oct 2025View details ↗
Phase 1RecruitingNCT07167537

A Study of OL-CD19-GDT in Relapsed/ Refractory Autoimmune Diseases

🏥 Beijing GoBroad Hospital📍 1 site📅 Started Oct 2025View details ↗
NARecruitingNCT07154667

Evaluation of the Auryzon™ EAR 2.0 System in Ear Reconstruction

👨‍⚕️ Angelo A Leto Barone, MD, Nemours Children's Hospital, Florida📍 1 site📅 Started Oct 2025View details ↗
RecruitingNCT07301892

Generative AI Impact on Rheumatoid Arthritis Complications Diagnosis

🏥 Guang'anmen Hospital of China Academy of Chinese Medical Sciences📍 1 site📅 Started Oct 2025View details ↗
Phase 2RecruitingNCT06887777

Efficacy and Safety of the Treatment of Pyruvate Dehydrogenase Deficiency Patients With Glycerol Phenylbutyrate (RAVICTI)

🏥 Assistance Publique - Hôpitaux de Paris📍 1 site📅 Started Oct 2025View details ↗
Phase 1RecruitingNCT07221240

Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Amisodin in Healthy Adult Subjects With Amyotrophic Lateral Sclerosis

🏥 PRG Science & Technology Co., Ltd.📍 1 site📅 Started Oct 2025View details ↗
Phase 2RecruitingNCT06790706

IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers

🏥 Hospices Civils de Lyon📍 15 sites📅 Started Oct 2025View details ↗
Phase 2Enrolling by InvitationNCT07172100

To Assess the Efficacy of Carica Papaya Leaf Extract in Improving Platelet Counts Among Pediatric Patients With Dengue-associated Thrombocytopenia

🏥 Ziauddin Hospital📍 1 site📅 Started Oct 2025View details ↗
Phase 1, PHASE2RecruitingNCT05751044

HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies

👨‍⚕️ Michel Zwaan, Prof. Dr., Princess Máxima Center📍 33 sites📅 Started Oct 2025View details ↗
Phase 1RecruitingNCT06940440

IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC)

👨‍⚕️ Andrew S Brohl, MD, Collaborator📍 2 sites📅 Started Oct 2025View details ↗
Phase 1Enrolling by InvitationNCT06429007

A Safety and Feasibility Trial Protocol of Metformin in Infants After Perinatal Brain Injury

👨‍⚕️ Brian Kalish, MD, Boston Children's Hospital📍 1 site📅 Started Oct 2025View details ↗
NARecruitingNCT07488728

Letermovir Prophylaxis in Children With EBV-Positive T/NK-Cell Lymphoproliferative Disease and Refractory/Relapsed EBV-Associated Hemophagocytic Lymphohistiocytosis

🏥 Beijing Children's Hospital📍 1 site📅 Started Oct 2025View details ↗
Phase 2, PHASE3RecruitingNCT06947928

Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma

👨‍⚕️ Andrew S Brohl, MD, Collaborator📍 8 sites📅 Started Oct 2025View details ↗
NARecruitingNCT07499284

A Multicenter, Randomized, Open-Label Study of Haplo-Cord HSCT for the Treatment of Aplastic Anemia

👨‍⚕️ Depei Wu, The First Affiliated Hospital of Soochow University📍 4 sites📅 Started Oct 2025View details ↗
Phase 1RecruitingNCT07198087

A Study to Investigate the Pharmacokinetics of Tirabrutinib in Participants With Mild, Moderate, and Severe Hepatic Impairment Compared to Healthy Participants

👨‍⚕️ Project Leader, Ono Pharmaceutical Co. Ltd📍 2 sites📅 Started Oct 2025View details ↗
Phase 2RecruitingNCT07175038

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

🏥 AllRock Bio, Inc.📍 13 sites📅 Started Oct 2025View details ↗
Phase 3Enrolling by InvitationNCT07204938

A Long-Term Study of Navenibart in Participants With Hereditary Angioedema

🏥 Astria Therapeutics, Inc.📍 1 site📅 Started Oct 2025View details ↗
← PreviousPage 59 of 513Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →